We are The Gator Nation, a diverse community dedicated to excellence in education and research and shaping a better future for Florida, the nation and the world. Our mission is to enable our students to lead and influence the next generation and beyond for economic, cultural and societal benefit.

University of Florida

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Investigating Metabolic Phenotypes for Sarcoidosis Diagnosis and Exploring Immunometabolic Profiles to Unravel Disease Mechanisms

Complete Genome Sequencing of the Novel Pseudomonas aeruginosa Phage UF_RH1

Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis

Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study

Dr. Mehdi Mirsaeidi is a highly skilled medical professional specializing in sarcoidosis, interstitial lung disease (ILD), and pulmonary infections. He is also director of the ILD and Sarcoidosis Program at UF Health in Jacksonville. With extensive expertise in these areas, Dr. Mirsaeidi excels in diagnosing and treating complex cases while also conducting groundbreaking research. Passionate about advancing patient care and outcomes, he is committed to staying at the forefront of medical advancements and implementing novel approaches in his practice. Driven by a deep sense of compassion, Dr. Mirsaeidi strives to provide the highest level of care to his patients, leveraging his knowledge and experience to improve their quality of life. With a strong dedication to education, he also actively contributes to the training and mentorship of future medical professionals.

His lab is interested in studying novel biomarkers that are involved in the mechanism of sarcoidosis, ILD and lung cancer. His team has discovered role of GHRHR in inflammation and lung cancer with a focus on small cell lung cancer (SCLC).

Media Inquiry